Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,247.50    5.00 (0.40%)
Bid:
1,235.00
Ask:
1,260.00
Spread: 25.00 (2.024%)
Market Cap: £369.26m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Further concentrate purchase

1 Oct 2007 07:02

Celtic Resources Holdings PLC01 October 2007 1 October 2007 Celtic Resources Holdings Plc ("Celtic" or the "Company") Celtic enters into agreement to purchase concentrates Celtic is pleased to announce that it has entered into an agreement with asubsidiary of European Goldfields Limited, Hellas Gold S.A. ("Hellas Gold"), forthe purchase of 50,000 tonnes of concentrates containing approximately 30,000 ozof gold. As announced on 22 September 2006, the Company acquired 9,000 tonnes ofconcentrate containing approximately 6,000 oz of gold, to be processed on atrial basis, by Celtic at its Suzdal BIOX(R) plant in Kazakhstan. The Companyalso announced that, if the initial shipments proved successful, it intended topurchase up to an additional 120,000 tonnes of concentrates from Hellas Gold.The Company has been very satisfied by the results of the trial and is thereforeannouncing an agreement to purchase a further 50,000 tonnes of concentrates,with shipments expected to be completed by the end of September 2009. The Company operates the only BIOX(R) plant in the FSU for the treatment ofrefractory sulphide ores and in addition to treating ore produced at its Suzdalmine, it will be utilising available BIOX(R) capacity to produce more gold. Suzdal has produced over 28,599 oz of gold in the last three months, whichincludes 11,780 oz produced in September, at an average sale price of US$718 peroz. Kevin Foo, Managing Director of Celtic, said, "We have been delighted with theresults of our initial trial to process third party concentrates at our SuzdalBIOX(R) plant. This agreement is a significant step forward in our strategy tocapitalise on our technology advantages at Suzdal and we are also looking atother third party concentrate opportunities within Kazakhstan and Russia, asmany refractory gold ores remain unexploited." Contact information: Kevin Foo / Jonathan Scott-BarrettCeltic Resources Holdings PlcTel: + 44 (0)20 7921 8800Investors@celtic resources.com Leesa Peters / Jane StaceyConduit PRTel: +44 (0)20 7429 6606 / (0)792 292 3306leesa@conduitpr.com Anthony CardewCardew GroupTel: +44 (0)20 7930 0777anthony.cardew@cardewgroup.com Strand Partners LimitedSimon RaggettStuart FaulknerTel: +44 (0)20 7409 3494 About the Suzdal BIOX(R) plant: Celtic has successfully developed the first BIOX(R) plant for treatment ofrefractory sulphide ores in the FSU at its Suzdal mine in Kazakhstan. The plantuses a sulphide oxidation process for recovering gold from refractory ores orconcentrates. The process utilises a mixed population of naturally occurringbacteria, that are present in all sulphide ores, to break down the sulphidemineral matrix, thereby liberating the occluded gold for subsequent cyanidation. The BIOX(R) process acts as an alternative to conventional processes of roastingand pressure oxidation and offers advantages of reduced capital cost, simplicityof operations, robustness and very low environmental impact. Any person who is the holder of 1 per cent. or more of any class of shares inCeltic may be required to make disclosures pursuant to Rule 8.3 of the IrishTakeover Panel Act, 1997, Takeover Rules 2001 to 2006. The Directors of Celtic accept responsibility for the information contained inthis announcement and to the best of their knowledge and belief (having takenall reasonable care to ensure that such is the case), the information containedin this announcement is in accordance with the facts and, where appropriate,does not omit anything likely to affect the import of such information. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Sep 20078:07 amRNSAcquisition
18th Sep 20077:01 amRNSAnnouncement of Approach
14th Sep 200711:35 amRNSHolding(s) in Company
13th Sep 20073:02 pmRNSResult of AGM
12th Sep 20077:02 amRNSInterim Results
11th Sep 200712:46 pmRNSAcquisition of Option
3rd Sep 20073:16 pmRNSHolding(s) in Company
30th Aug 20079:44 amRNSHolding(s) in Company
29th Aug 20077:00 amRNSAppoints Co-Broker
23rd Aug 20071:11 pmRNSCorrected - Acquisition
23rd Aug 200712:24 pmRNSAcquisition
23rd Aug 200712:23 pmRNSAcquisition
23rd Aug 200712:22 pmRNSAcquisition
17th Aug 200711:54 amRNSAim Rule 26
15th Aug 20075:40 pmRNSHolding(s) in Company
15th Aug 20075:31 pmRNSAcquisition
15th Aug 200711:39 amRNSAGM Statement
14th Aug 20071:22 pmRNSDirector/PDMR Shareholding
14th Aug 20079:07 amRNSSeverstal strategic holding
14th Aug 20077:33 amRNSAcquisition
10th Aug 200712:15 pmRNSHolding(s) in Company
8th Aug 20077:00 amRNSHolding(s) in Company
7th Aug 20075:30 pmRNSAcquisition - SAR 6
31st Jul 200712:43 pmRNSTotal Voting Rights
31st Jul 200712:41 pmRNSHolding(s) in Company
31st Jul 20077:01 amRNSDisposal
26th Jul 200711:13 amRNSAcquisition
19th Jul 20076:00 pmRNSDirector/PDMR Shareholding
19th Jul 20075:43 pmRNSHolding(s) in Company
19th Jul 20077:00 amRNSChange of Adviser
17th Jul 20077:00 amRNSDirectorate Change
5th Jul 20075:29 pmRNSHolding(s) in Company
2nd Jul 20075:17 pmRNSDirector/PDMR Shareholding
29th Jun 200710:03 amRNSPublication of annual r&a
20th Jun 20078:31 amRNSAdditional Listing
19th Jun 20077:01 amRNSFinal Results
12th Jun 20077:00 amRNSFarm out agreement
8th Jun 200712:26 pmRNSHolding(s) in Company
30th May 20077:01 amRNSResource update
29th May 20076:19 pmRNSDirector/PDMR Shareholding
25th May 20079:56 amRNSHolding(s) in Company
24th May 20079:47 amRNSNew Molybdenum Projects
18th May 20073:22 pmRNSHolding(s) in Company
19th Apr 20074:07 pmRNSChange in director's interest
18th Apr 20077:00 amRNSTrading on PLUS
4th Apr 20075:23 pmRNSHolding in Company
20th Mar 20074:39 pmRNSDirector/PDMR Shareholding
5th Mar 20077:01 amRNS2nd joint venture agreemnt
19th Feb 20077:01 amRNSSale of Gekko Equipment
15th Feb 20077:01 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.